Doug Smith
Dec. 1, 2025 - The Board of Directors of CellMark Investment AB recently appointed Doug Smith as the new President and Chief Executive Officer of CellMark, effective October 13, 2025. Smith will be based in Toronto, Canada, but work regularly from CellMark's headquarters in Gothenburg, Sweden.
Smith replaces Henrik Forsberg Schoultz, who in October notified the Board of his decision to resign from the company.
"The Board of Directors extends its sincere appreciation to Henrik for his dedication and valuable contributions during 8 years in the company and wishes him every success in all his future endeavours," CellMark stated in a news release.
Smith has had a successful and varied career in a multitude of industries. He brings over 20 years of experience in the pulp industry, having worked on both the agency and producer sides. He began his career as a retail entrepreneur in Ontario, Canada, and later launched a start-up manufacturing facility that introduced the world's first engineered coated board.
Smith first joined CellMark in 2009. Since 2014, he has successfully led CellMark's founding division, CellMark Pulp, driving performance and demonstrating strong leadership. Beginning in 2019, he joined CellMark's Board of Directors, a role he will continue alongside his new position.
The Board of Directors is confident that Doug's extensive industry experience, as well as alignment with CellMark's distinctive culture and management style, makes him the ideal leader for the company's next chapter.
Smith will retain his responsibilities as President of CellMark Pulp for a period of time to ease the transition.
CellMark is an employee-owned, independent sales solution company providing products, services, and solutions to customers and suppliers all over the world. CellMark provides a full suite of services and runs several successful international divisions within the areas of pulp, packaging, paper, recycling, chemicals, and basic materials. CellMark trades over 7 million tons of products annually with revenue of over USD 3.7 billion.
SOURCE: CellMark